Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

300.50p
   
  • Change Today:
    -10.00p
  • 52 Week High: 445.00
  • 52 Week Low: 190.40
  • Currency: UK Pounds
  • Shares Issued: 105.98m
  • Volume: 452,898
  • Market Cap: £318.46m
  • RiskGrade: 125
  • Beta: 0.02

OXB Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -205.7% -32.2%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 3.7 3.3
Pr/Book 4.2  
Latest F'cast
Revenue -36.0% 43.3%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

OXB Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 64.06 (20.89) (22.10)p n/a n/a n/a n/a 0.0%
31-Dec-20 87.73 (6.57) (7.81)p n/a n/a n/a n/a 0.0%
31-Dec-21 142.80 19.88 22.77p 54.0 n/a n/a n/a 0.0%
31-Dec-22 139.99 (45.98) (41.29)p n/a n/a n/a n/a 0.0%
31-Dec-23 89.54 (188.53) (163.11)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

OXB Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 128.34 (41.29) (44.31)p n/a n/a n/a n/a 0.0%
31-Dec-25 164.93 (19.45) (30.15)p n/a n/a n/a n/a 0.0%
31-Dec-26 210.29 7.45 (8.83)p n/a n/a n/a n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

OXB Company Announcements

Director Declaration 27-Mar-2025 16:45 RNS
Total Voting Rights 03-Mar-2025 09:00 RNS
Holding(s) in Company 20-Feb-2025 15:42 RNS

OXB ShareCast News

Oxford Biomedica reports first-half revenue growth 23-Sep-2024 ShareCast
Oxford Biomedica still expecting small loss afte... 08-Aug-2024 ShareCast
Oxford Biomedica appoints new finance chief 17-Jul-2024 ShareCast

OXB Top Newspaper Links

Need to know: Opec cuts forecast ... Tesco cuts ... 16-Aug-2008 Times
Need to know 10-May-2008 Times
DSG International may be losing its spark 12-Feb-2008 Telegraph

Latest OXB Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

OXB Market Data

Currency UK Pounds
Share Price 300.50p
Change Today -10.00p
% Change -3.22 %
52 Week High 445.00
52 Week Low 190.40
Volume 452,898
Shares Issued 105.98m
Market Cap £318.46m
Beta 0.02
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
26.58% below the market average26.58% below the market average26.58% below the market average26.58% below the market average26.58% below the market average
10.64% above the sector average10.64% above the sector average10.64% above the sector average10.64% above the sector average10.64% above the sector average
Price Trend
1.36% above the market average1.36% above the market average1.36% above the market average1.36% above the market average1.36% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Income Not Available
Growth
50.2% below the market average50.2% below the market average50.2% below the market average50.2% below the market average50.2% below the market average
48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average

What The Brokers Say

Strong Buy 3
Buy 3
Neutral 4
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 31-Mar-2025

Time Volume / Share Price
13:27 40 @ 300.50p
13:27 429 @ 300.50p
13:27 216 @ 300.50p
13:24 1 @ 300.50p
13:24 55 @ 300.00p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page